Trastuzumab Injection is used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. As part of chemotherapy regimen for adjuvant treatment of lymph-node positive, HER2/neu protein positive breast cancer. Treatment of gastric (stomach) cancer.
Bevacizumab injection products are used in combination with atezolizumab to treat hepatocellular carcinoma (HCC) that has spread or cannot be removed by surgery in people who have not previously not received chemotherapy.
Sunitinib is used to treat gastrointestinal stromal tumors (GIST; a type of tumor that grows in the stomach, intestine (bowel), or esophagus (tube that connects the throat with the stomach) in people with tumors that were not treated successfully with imatinib (Gleevec) or people who cannot take imatinib.
Decitabine is a nucleoside metabolic inhibitor indicated in order to treat patients with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Doxorubicin Hydrochloride Injection specifically is an anthracycline topoisomerase II inhibitor often used along with other chemotherapy agents for the treatment of different types of cancer include, Adjuvant Breast Cancer, Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Hodgkin Lymphoma etc..